Mielóma multiplex: vizsgálatok itt: Kína
26 of 204 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseCsak meghívásosLong-term Follow-up Study in Subjects With Multiple Myeloma Previously Treated With GC012F Injection
- Where
- Shanghai
- People
- 40
- Run by
- RenJi Hospital
See details and how to joinNCT07833046 - No phaseTaking peopleA Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH
- Where
- Beijing
- People
- 2000
- Run by
- Peking University First Hospital
See details and how to joinNCT05283993 - No phaseTaking peopleLow-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients
- Where
- Hainan
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Haikou Affiliated Hospital of Central South University Xiangya School of Medicine
See details and how to joinNCT07763054 - No phaseTaking peopleLongitudinal Data Registry of Plasma Cell Dyscrasia
- Where
- Shanghai
- Életkor
- 19 év to 99 év
- People
- 2000
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT06760052 - No phaseTaking peopleIsatuximab-VRd in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients
- Where
- Beijing, Chengdu, Guangzhou, Harbin, Kunming, Naning, Nanjing, Nantong, Shanghai, Shenzhen, Wuhan, Xi’an, Zhengzhou
- Életkor
- 18 év and over
- People
- 333
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT07663253 - No phaseTaking peoplePredicting Response to Selinexor-Based Therapy in Relapsed/Refractory Multiple Myeloma: A Multicenter Prospective Study
- Where
- Taiyuan
- Életkor
- 18 év and over
- People
- 127
- Run by
- Shanxi Bethune Hospital
See details and how to joinNCT07514052 - No phaseTaking peopleDara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma
- Where
- Changchun
- Életkor
- 18 év and over
- People
- 50
- Run by
- FengYan Jin
See details and how to joinNCT06252792 - No phaseTaking peopleEpunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma
- Where
- Taiyuan
- Életkor
- 18 év to 75 év
- People
- 48
- Run by
- Shanxi Bethune Hospital
See details and how to joinNCT07497165 - No phaseCsak meghívásosAI-Based Fine Morphological Subtyping of Myeloma Single Cells for Predicting FISH Abnormalities
- Where
- Wuhan
- People
- 10
- Run by
- Fuling Zhou
See details and how to joinNCT07410403 - No phaseTaking peopleNational Longitudinal Cohort of Hematological Diseases
- Where
- Tianjin
- People
- 2300
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT04645199 - No phaseTaking peopleIndividualized Dynamic Frailty-tailored Therapy (DynaFiT) in Elderly Patients With NDMM
- Where
- Changchun
- Életkor
- 65 év and over
- People
- 131
- Run by
- FengYan Jin
See details and how to joinNCT06099912 - No phaseNot yet taking people in KínaASPIRE: A Registry Study Of Chinese Patients With TCE-RRMM Treated By Elranatamab
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 159
- Run by
- Peking University People's Hospital
See details and how to joinNCT07320326 - No phaseTaking peopleReal-world Immuno-therapy in Chinese Newly Diagnosed Multiple Myeloma Patients
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 500
- Run by
- Peking University People's Hospital
See details and how to joinNCT07296627 - No phaseTaking peopleHigh-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
- Where
- Xining
- People
- 1000
- Run by
- Yigeng Cao,MD,PhD
See details and how to joinNCT07205523 - No phaseNot yet taking people in KínaRisk-adapted Therapeutic Strategy in +1q NDMM
- Where
- Changchun
- People
- 200
- Run by
- FengYan Jin
See details and how to joinNCT07045168 - No phaseTaking peopleA Prospective Study Comparing DRd With VRd-lite in Elderly Newly Diagnosed Multiple Myeloma
- Where
- Changzhou, Nanjing, Nantong, Taizhou, Yancheng
- Életkor
- 65 év and over
- People
- 112
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06497738 - No phaseTaking peopleLong-term Follow-up Registry Study of Equecabtagene Autoleucel Injection
- Where
- Beijing, Tianjin, Wuhan, Zhengzhou
- People
- 1500
- Run by
- Nanjing IASO Biotechnology Co., Ltd.
See details and how to joinNCT07028970 - No phaseTaking peopleThe Prognostic Value of CPCs Quantified by Flow Cytometry in Patients With Multiple Myeloma: a Prospective, Multicenter Clinical Trial
- Where
- Wuhan
- Életkor
- 18 év to 80 év
- People
- 458
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06228794 - No phaseTaking peopleScreening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis
- Where
- Guangzhou
- People
- 200
- Run by
- Zhujiang Hospital
See details and how to joinNCT05686447 - No phaseTaking peopleCharacteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy
- Where
- Guanzhou
- Életkor
- 45 év and over
- People
- 2990
- Run by
- Zhujiang Hospital
See details and how to joinNCT06690593 - No phaseTaking peopleConversion to Carfilzomib Therapy in Bortezomib Intolerant Newly Diagnosed Multiple Myeloma(NDMM) Patients
- Where
- Suzhou
- Életkor
- 18 év and over
- People
- 50
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT06682156 - No phaseTaking peopleIntestinal Flora and Immunity in Monoclonal Gammopathy Patients
- Where
- Guanzhou
- Életkor
- 45 év and over
- People
- 300
- Run by
- Zhujiang Hospital
See details and how to joinNCT06539832 - No phaseTaking peoplePrimary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not
- Where
- Hangzhou
- Életkor
- 18 év to 70 év
- People
- 210
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT06463717 - No phaseNot yet taking people in KínaA Real World Study of Equecabtagene Autoleucel in Subjects With Relapsed and Refractory Multiple Myeloma.
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 260
- Run by
- Peking University People's Hospital
See details and how to joinNCT06369935 - No phaseTaking peopleCardiac Toxicity and Prognostic Value of New Echocardiographic Indicators in the Treatment of Primary Multiple Myeloma
- Where
- Jinan
- Életkor
- 18 év to 70 év
- People
- 50
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT06039735